FOR IMMEDIATE RELEASE
DATE: January 28, 2022
CONTACT: Debbie Rich, PMD Alliance Director, Community Development 800-256-0966 or email@example.com
As part of PMD Alliance’s APProviders™ Consortium, PMD Alliance offers free, monthly CME courses for Advanced Practice Providers (APPs)by APPs in movement and related disorders. The APProviders™ Consortium addresses an unmet need, a lack of access to continuing medical education specific to movement disorders for APPs—Nurse Practitioners (NP) and Physician Assistants (PA). By releasing these courses, PMD Alliance is equipping APPs with resources to best serve their patients and further their work in movement and related disorders. This is one of many services provided to APPs through our APProviders™ Consortium.
The latest CME course released by PMD Alliance is Sleep Disturbance in Patients with Parkinson’s Disease.
About Sleep Disturbance in Patients with Parkinson’s Disease
It’s estimated that approximately 930,000 Americans live with Parkinson disease. Up to 98% of them experience sleep disturbance (SD), which can include excessive daytime sleepiness (EDS), insomnia, sleep fragmentation (waking up multiple times a night), nocturnal motor features, dream enactment, restless leg syndrome, or obstructive sleep apnea.
Sleep disturbance (SD) is one of the most common and debilitating non-motor manifestations of Parkinson disease, intensifying disease-related disabilities of motor and non-motor symptoms. In spite of this, it’s often under-recognized and under-addressed by healthcare professionals. Adding to the confusion is that there isn’t a standardized approach to assessing sleep difficulties, making it harder to target treatment appropriately.
In this course, learners will acquire a deeper understanding not only of the importance and prevalence of sleep disturbances in patients with movement disorders; they’ll explore how to screen for SD and offer solutions. The course’s learning objectives are:
• Describe the prevalence and variety of sleep disturbance in patients with Parkinson disease.
• Recognize the importance of sleep in neurodegeneration.
• Classify screening tools for sleep disturbance.
• Employ Parkinson disease specific screening tools such as PDSS – 2 in clinical practice.
• Manage sleep disturbance in patients with Parkinson disease.
• Evaluate patient perspectives on sleep and the correlation with quality of life.
Faculty member Jenny Nguyen, MSN, FNP-C, from Cleveland Clinic Lou Ruvo Center for Brain Health, explains that sleep is key on many levels. “Sleep enables the brain to rest and [allows for] the regeneration of neurons and neurotransmitters.” Parkinson disease or not, healthy sleep means a healthier brain. For APPs in movement and related disorders, understanding and learning how to best screen for sleep disturbance is crucial to patient wellbeing. When sleep disturbance is left untreated, it can lead to increased rigidity, tremors, dystonia, anxiety, depression, poor cognition, and even hallucinations (among other symptoms). When healthcare professionals like APPs are equipped to recognize SD and offer management options, patients experience greater physical and mental health and a significantly enhanced quality of life. Nguyen goes on to explain that addressing SD not only positively impacts the patient, but “reduces caregiver burden,” too.
This CME is a crucial topic that will help APPs provide critical patient management and education to the movement disorder community, who are overwhelmingly impacted by sleep disturbances.
Sleep Disturbance in Patients with Parkinson’s Disease is jointly provided by Postgraduate Institute for Medicine and Parkinson & Movement Disorder Alliance, and it relies on the expertise of our faculty: Jenny Nguyen, MSN, FNP-C.